InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
- Company Receives Allowance of Patent Claims in the U.S. and in India - - InNexus Biotechnology CEO Highlighted in Nature Biotechnology - InNexus Biotechnology Inc. (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic more